Merrion Pharma is understood to be contacting broking firms to advise clients to vote on the company’s winding-up plan.
Merrion, a drug company backed by Declan Ryan, announced last month that it planned to voluntarily wind up and hand back €4.5 million of cash to investors. After selling intellectual property assets last year to drug giant Novo, Nordisk Merrion set about turning itself into an investment company focused on the healthcare sector, but...
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
Then €19.99 a month after the offer period.
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Get a Business Account for you and your team